CN1748761A - Pill medicine for treating mastosis - Google Patents

Pill medicine for treating mastosis Download PDF

Info

Publication number
CN1748761A
CN1748761A CNA2005100103507A CN200510010350A CN1748761A CN 1748761 A CN1748761 A CN 1748761A CN A2005100103507 A CNA2005100103507 A CN A2005100103507A CN 200510010350 A CN200510010350 A CN 200510010350A CN 1748761 A CN1748761 A CN 1748761A
Authority
CN
China
Prior art keywords
grams
pill
treating
treatment
mastosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2005100103507A
Other languages
Chinese (zh)
Other versions
CN1311851C (en
Inventor
赵传义
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100103507A priority Critical patent/CN1311851C/en
Publication of CN1748761A publication Critical patent/CN1748761A/en
Application granted granted Critical
Publication of CN1311851C publication Critical patent/CN1311851C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The mastosis treating medicine pill is prepared with seven kinds of Chinese medicinal materials, including anemarrhena rhizome, phellodendron bark, pangolin scales, momordica seed, nutagrass flatsedge seed, bupleurum root and licorice. The medicine pill of the present invention is used in treating mastitis, mammary gland lobule proliferation and galactophorous duct dilatation, and has the features of high curative effect, small dosage and fast acting.

Description

The mastotic pill of a kind of treatment
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of pill for the treatment of mastitis, cyclomastopathy.
Background technology
Cyclomastopathy is a kind of non-inflammation shape disease of breast portion, and characteristics are that breast scatters lump, increase the weight of through before swelling and ache, through after alleviate, sickness rate is very high in the women, can be described as the early stage omen of canceration, this disease traditional Chinese medical science is called " nodules of the breast " again.Mastitis, the traditional Chinese medical science claims acute mastitis, is the acute suppurative inflammation of breast portion, shows as local red and swollen heat pain, pilosity is born in age of sucking in puerperal.Mastopathy is commonly encountered disease, frequently-occurring disease, and women's physical and mental health is had bigger influence.All treatment should focus on the principal cause of a disease, though it is not the mastopathy origin cause of formation is many, always outer by due to the hyperactivity of fire induced glandular secretion functional disorder in the moon.The medicine of now treating this disease has: RUPIXIAO, and asparagines etc. take effect slowly but all exist, and the course of treatment is long, the shortcoming that cure rate is low.
Summary of the invention
The object of the present invention is to provide a kind of short treating period, the mastotic pill of the treatment that cure rate is high.
With Rhizoma Anemarrhenae Cortex Phellodendri nourishing YIN to lower pathogenic fire, the adjustment incretion balance is monarch in the crude drug of the present invention; Squama Manis, Semen Momordicae softening hardness and disperse swelling, dispelling toxicity, detoxicating promotes hyperplastic tissue to be absorbed as minister, and Rhizoma Cyperi, the fast air to open of Radix Bupleuri are strongly fragrant, and soothing liver-QI is analgesic, strengthens lactiferous gland rehabilitation soup and is assistant; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is collaborative, supplements and complements each other, thereby can effectively treat mastitis and cyclomastopathy.
The weight ratio of crude drug of the present invention is: Rhizoma Anemarrhenae 15-25%, Cortex Phellodendri 15-25%, Squama Manis 12-20% gram, Semen Momordicae 12-20%, Rhizoma Cyperi 12-20%, Radix Bupleuri 10-15% and Radix Glycyrrhizae 10-15%.
Be preferably: the Rhizoma Anemarrhenae 25 grams, Cortex Phellodendri 25 grams, Squama Manis 20 grams, Semen Momordicae 20 grams, Rhizoma Cyperi 20 grams, Radix Bupleuri 15 grams and Radix Glycyrrhizae 15 grams.
The preparation method that the present invention treats mastotic pill is identical with conventional pill preparation method.
The every ball of pill of the present invention weighs 2 grams, oral 2 times of every day, each ball.
Crude drug of the present invention is compatible to have nourishing YIN to lower pathogenic fire, softening hardness and disperse swelling, dispelling toxicity, detoxicating, the fast strongly fragrant effect of air to open.Pill consumption of the present invention is little, instant effect, and short treating period, the curative effect brilliance, the cure rate height does not recur after healing.Acute and chronic mastitis, cyclomastopathy and comedomastitis all there is specially good effect.
The specific embodiment
Below further set forth the beneficial effect of pill of the present invention by clinical observation on the therapeutic effect test.
1, physical data: accept patient male's 1 example for medical treatment, women's 93 examples, female age is at 25-50 between year.
2, diagnostic criteria: mammary swelling, pain, lump not of uniform size is arranged, the both arms activity is restricted, and scanning can be made a definite diagnosis by instrument.
3, Therapeutic Method: oral 2 times of every day, each ball, 12 days is a course of treatment.
4, efficacy assessment standard: cure: lump complete obiteration, mastalgia disappear, and do not recur after the drug withdrawal; Take a turn for the better: the lump area reduces, and mastalgia alleviates; Invalid: as not reach improvement standard person.
5, result: cure male 1 example, women 85 examples.4 examples that take a turn for the better, invalid 4 examples.In invalid 4 examples, 3 routine concurrent mammary gland fibroma are arranged, so not in the treatment category of this medicine.Light and medical history weak point person can be healed 1-2 the course of treatment, and old prolonged illness and recurrence after operation person 3-4 can be healed the course of treatment, does not recur after healing.Effective percentage is more than 98%, and cure rate is more than 90%.

Claims (2)

1, the mastotic pill of a kind of treatment is characterized in that it is to be made by the crude drug of following weight ratio: Rhizoma Anemarrhenae 15-25%, Cortex Phellodendri 15-25%, Squama Manis 12-20% gram, Semen Momordicae 12-20%, Rhizoma Cyperi 12-20%, Radix Bupleuri 10-15% and Radix Glycyrrhizae 10-15%.
2, the mastotic pill of a kind of treatment according to claim 1 is characterized in that the crude drug consumption: the Rhizoma Anemarrhenae 25 grams, Cortex Phellodendri 25 grams, Squama Manis 20 grams, Semen Momordicae 20 grams, Rhizoma Cyperi 20 grams, Radix Bupleuri 15 grams and Radix Glycyrrhizae 15 grams.
CNB2005100103507A 2005-09-17 2005-09-17 Pill medicine for treating mastosis Expired - Fee Related CN1311851C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100103507A CN1311851C (en) 2005-09-17 2005-09-17 Pill medicine for treating mastosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100103507A CN1311851C (en) 2005-09-17 2005-09-17 Pill medicine for treating mastosis

Publications (2)

Publication Number Publication Date
CN1748761A true CN1748761A (en) 2006-03-22
CN1311851C CN1311851C (en) 2007-04-25

Family

ID=36604538

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100103507A Expired - Fee Related CN1311851C (en) 2005-09-17 2005-09-17 Pill medicine for treating mastosis

Country Status (1)

Country Link
CN (1) CN1311851C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979082A (en) * 2010-10-27 2011-02-23 中国科学院昆明植物研究所 Medicament for treating cyclomastopathy and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083275C (en) * 1999-06-11 2002-04-24 郭增才 Medicine for treating breast tumor and carbuncle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979082A (en) * 2010-10-27 2011-02-23 中国科学院昆明植物研究所 Medicament for treating cyclomastopathy and preparation method and application thereof
CN101979082B (en) * 2010-10-27 2012-03-07 中国科学院昆明植物研究所 Medicament for treating cyclomastopathy and preparation method and application thereof

Also Published As

Publication number Publication date
CN1311851C (en) 2007-04-25

Similar Documents

Publication Publication Date Title
CN100434107C (en) Acne clearing decoction
CN102940853B (en) Navel paste for treating mammary gland hyperplasia diseases
CN101732558A (en) Traditional Chinese medicine granules used for treating chronic pharyngitis
CN101491663B (en) Traditional Chinese medicine composition for treating various cancer
CN101822806A (en) Traditional Chinese medicine composition for treating lung cancer and preparation method thereof
CN1879857A (en) Medicinal powder for treating mammary gland disease
CN101214357A (en) Pharmaceutical composition for treating chronic prostatitis
CN100444889C (en) Chinese medicinal composition for treating mastopathy
CN103585521A (en) Traditional Chinese medicine composition for treating indigestion and food stagnation
CN102258603B (en) Medicinal preparation for treating plasma cell mastitis and preparation method thereof
CN1679661A (en) Medicine for treating female mazoplasia and preparation thereof
CN104524247B (en) One treats migrainous medical composition and its use
CN101757521B (en) Traditional Chinese medicine for treating proliferation of mammary gland
CN1311851C (en) Pill medicine for treating mastosis
CN101732500A (en) Medicine for preventing and treating acute and chronic pharyngitis and sphagitis
CN101019941A (en) Chinese medicine prepn for treating osteochondrosis of tibial tubercle and other diseases
CN103610940A (en) Traditional Chinese medicinal composition for treating toothache
CN104623379A (en) Medicine composition for treating infantile hand-foot-mouth diseases
CN1593587A (en) Lung nourishing and regulating pill for treating lung system diseases and preparation method thereof
CN101537080B (en) Pine needle health-care medicinal liquor with efficacy of dispersing pathogenic wind and removing dampness and preparation method thereof
CN113813344B (en) Composition for treating joint pain and mastitis of lying-in women and application thereof
CN102670807A (en) Medicine composition for treating prostatitis and preparation method and application thereof
CN101433672B (en) Chinese medicament preparation for treating nosebleed and preparation method thereof
CN107335011A (en) Treat the external application Chinese medicine compound preparation of cancer pain
CN106620121A (en) Traditional Chinese medicine composition for treating mammary gland hyperplasia caused by stagnation of qi due to depression of the liver

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070425

Termination date: 20091019